- Home
- XTNT vs SURG Comparison
XTNT vs SURG Comparison
Compare XTNT & SURG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XTNT
- SURG
- Stock Information
- Founded
- XTNT N/A
- SURG 2006
- Country
- XTNT United States
- SURG United States
- Employees
- XTNT N/A
- SURG N/A
- Industry
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- SURG Advertising
- Sector
- XTNT Health Care
- SURG Consumer Discretionary
- Exchange
- XTNT Nasdaq
- SURG Nasdaq
- Market Cap
- XTNT 60.9M
- SURG 56.5M
- IPO Year
- XTNT N/A
- SURG N/A
- Fundamental
- Price
- XTNT $0.61
- SURG $2.70
- Analyst Decision
- XTNT
- SURG Strong Buy
- Analyst Count
- XTNT 0
- SURG 1
- Target Price
- XTNT N/A
- SURG $9.00
- AVG Volume (30 Days)
- XTNT 57.0K
- SURG 84.4K
- Earning Date
- XTNT 08-07-2025
- SURG 08-12-2025
- Dividend Yield
- XTNT N/A
- SURG N/A
- EPS Growth
- XTNT N/A
- SURG N/A
- EPS
- XTNT N/A
- SURG N/A
- Revenue
- XTNT $122,298,000.00
- SURG $40,029,467.00
- Revenue This Year
- XTNT $11.64
- SURG $124.78
- Revenue Next Year
- XTNT $7.59
- SURG $49.21
- P/E Ratio
- XTNT N/A
- SURG N/A
- Revenue Growth
- XTNT 20.81
- SURG N/A
- 52 Week Low
- XTNT $0.33
- SURG $1.05
- 52 Week High
- XTNT $0.83
- SURG $3.52
- Technical
- Relative Strength Index (RSI)
- XTNT 48.62
- SURG 47.31
- Support Level
- XTNT $0.57
- SURG $2.70
- Resistance Level
- XTNT $0.68
- SURG $2.95
- Average True Range (ATR)
- XTNT 0.05
- SURG 0.17
- MACD
- XTNT -0.02
- SURG -0.03
- Stochastic Oscillator
- XTNT 30.44
- SURG 27.91
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.
About SURG SurgePays Inc.
Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; and Others. It generates the majority of its revenue from the Mobile Virtual Network Operators segment.